Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
21 03 2023
Historique:
pubmed: 18 3 2023
medline: 23 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Background Tricuspid regurgitation (TR) frequently develops in patients with long-standing pulmonary hypertension, and both pathologies are associated with increased morbidity and mortality. This study aimed to improve prognostic assessment in patients with severe TR undergoing transcatheter tricuspid valve intervention (TTVI) by relating the extent of TR to pulmonary artery pressures. Methods and Results In this multicenter study, we included 533 patients undergoing TTVI for moderate-to-severe or severe TR. The proportionality framework was based on the ratio of tricuspid valve effective regurgitant orifice area to mean pulmonary artery pressure. An optimal threshold for tricuspid valve effective regurgitant orifice area/mean pulmonary artery pressure ratio was derived on 353 patients with regard to 2-year all-cause mortality and externally validated on 180 patients. Patients with a tricuspid valve effective regurgitant orifice area/mean pulmonary artery pressure ratio ≤1.25 mm

Identifiants

pubmed: 36926925
doi: 10.1161/JAHA.122.028737
pmc: PMC10111550
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028737

Références

N Engl J Med. 2018 Dec 13;379(24):2307-2318
pubmed: 30280640
Eur Heart J. 2019 Feb 1;40(5):476-484
pubmed: 30351406
Eur Heart J. 2019 Feb 1;40(5):485-487
pubmed: 30689817
EuroIntervention. 2021 Jul 20;17(4):e343-e352
pubmed: 33956637
J Am Coll Cardiol. 2019 Dec 17;74(24):2998-3008
pubmed: 31568868
Open Heart. 2022 Oct;9(2):
pubmed: 36261218
Eur Heart J. 2018 Apr 14;39(15):1255-1264
pubmed: 29281101
JACC Cardiovasc Interv. 2021 Oct 25;14(20):2246-2256
pubmed: 34600873
Eur Heart J. 2017 Dec 01;38(45):3351-3358
pubmed: 29020232
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1342-1343
pubmed: 28977455
Eur Heart J. 2020 Aug 1;41(29):2785-2795
pubmed: 32176280
J Am Coll Cardiol. 2004 Feb 4;43(3):405-9
pubmed: 15013122
J Am Soc Echocardiogr. 2022 Jan;35(1):105-115.e8
pubmed: 34389469
Prog Cardiovasc Dis. 2019 Nov - Dec;62(6):447-451
pubmed: 31707061
JACC Cardiovasc Imaging. 2019 Apr;12(4):652-664
pubmed: 30947907
J Am Coll Cardiol. 2022 Feb 8;79(5):462-464
pubmed: 35115102
Int J Cardiol. 2020 Oct 15;317:176-180
pubmed: 32512064
J Am Coll Cardiol. 2022 Aug 23;80(8):783-800
pubmed: 35595203
N Engl J Med. 2018 Dec 13;379(24):2297-2306
pubmed: 30145927
Am J Cardiol. 2019 Sep 1;124(5):772-780
pubmed: 31280838
JACC Cardiovasc Imaging. 2021 Apr;14(4):742-752
pubmed: 32950444
Eur Heart J Cardiovasc Imaging. 2020 Feb 1;21(2):157-165
pubmed: 31544933
JACC Cardiovasc Interv. 2022 Feb 28;15(4):381-394
pubmed: 35210045
EuroIntervention. 2021 Nov 19;17(10):791-808
pubmed: 34796878
Eur Heart J. 2020 May 21;41(20):1930-1931
pubmed: 32337531
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128
pubmed: 29929631
Circ Cardiovasc Interv. 2021 Aug;14(8):e010437
pubmed: 34266311
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362
pubmed: 30553663
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
JACC Cardiovasc Interv. 2021 Jan 11;14(1):29-38
pubmed: 33309317
JACC Cardiovasc Imaging. 2021 Jun;14(6):1085-1095
pubmed: 33582056
JACC Cardiovasc Interv. 2021 Oct 11;14(19):2127-2140
pubmed: 34620391
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Eur Heart J Digit Health. 2022 Apr 22;3(2):153-168
pubmed: 36713009
Am J Cardiol. 2021 Jun 1;148:138-145
pubmed: 33667451
J Am Coll Cardiol. 2022 Feb 8;79(5):448-461
pubmed: 35115101

Auteurs

Vera Fortmeier (V)

Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia Ruhr University Bochum Bad Oeynhausen Germany.

Mark Lachmann (M)

First Department of Medicine, Klinikum rechts der Isar Technical University of Munich Munich Germany.
DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance Munich Germany.

Matthias Unterhuber (M)

Department of Cardiology, Heart Center Leipzig University of Leipzig Leipzig Germany.

Lukas Stolz (L)

Medizinische Klinik und Poliklinik I Klinikum der Universität München, Ludwig Maximilians University of Munich Munich Germany.

Mohammad Kassar (M)

Department of Cardiology Inselspital Bern, Bern University Hospital Bern Switzerland.

Laurin Ochs (L)

Department of Cardiology, Heart Center University of Cologne Cologne Germany.

Muhammed Gerçek (M)

Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia Ruhr University Bochum Bad Oeynhausen Germany.

Anne R Schöber (AR)

Department of Cardiology, Heart Center Leipzig University of Leipzig Leipzig Germany.

Thomas J Stocker (TJ)

DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance Munich Germany.
Medizinische Klinik und Poliklinik I Klinikum der Universität München, Ludwig Maximilians University of Munich Munich Germany.

Hazem Omran (H)

Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia Ruhr University Bochum Bad Oeynhausen Germany.

Maria I Körber (MI)

Department of Cardiology, Heart Center University of Cologne Cologne Germany.

Amelie Hesse (A)

First Department of Medicine, Klinikum rechts der Isar Technical University of Munich Munich Germany.
DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance Munich Germany.

Kai Peter Friedrichs (KP)

Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia Ruhr University Bochum Bad Oeynhausen Germany.

Shinsuke Yuasa (S)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Tanja K Rudolph (TK)

Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia Ruhr University Bochum Bad Oeynhausen Germany.

Michael Joner (M)

DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance Munich Germany.
Department of Cardiology, German Heart Center Munich Technical University of Munich Munich Germany.

Roman Pfister (R)

Department of Cardiology, Heart Center University of Cologne Cologne Germany.

Stephan Baldus (S)

Department of Cardiology, Heart Center University of Cologne Cologne Germany.

Karl-Ludwig Laugwitz (KL)

First Department of Medicine, Klinikum rechts der Isar Technical University of Munich Munich Germany.
DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance Munich Germany.

Fabien Praz (F)

Department of Cardiology Inselspital Bern, Bern University Hospital Bern Switzerland.

Stephan Windecker (S)

Department of Cardiology Inselspital Bern, Bern University Hospital Bern Switzerland.

Jörg Hausleiter (J)

DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance Munich Germany.
Medizinische Klinik und Poliklinik I Klinikum der Universität München, Ludwig Maximilians University of Munich Munich Germany.

Philipp Lurz (P)

Department of Cardiology, Heart Center Leipzig University of Leipzig Leipzig Germany.

Volker Rudolph (V)

Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia Ruhr University Bochum Bad Oeynhausen Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH